Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1989-12-26
1992-08-04
Schenkman, Leonard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3134
Patent
active
051359464
ABSTRACT:
The use of 2,4-monofurfurylidene-sorbitol and 2,4-monofurfurylidene-1,3,5,6-0-tetraalkylsorbitol wherein the alkyls are linear or branched C.sub.1 -C.sub.4, in the preparation of cosmetics and dermatology compositions for preventing premature ageing of the skin caused by free radicals which form in the skin either physiologically or by the effect of environmental pollutant substances or radiation.
Said compositions are in the form of creams, gels, lotions, sprays, etc., and contain between 0.5 and 2% by weight or 2,4-monofurfurylidene-sorbitol or 2,4-monofurfurylidene-1,3,5,6-0-tetraalkylsorbitol.
REFERENCES:
patent: 3383279 (1968-05-01), Garzia
patent: 3551554 (1970-12-01), Herschler
patent: 4557934 (1985-12-01), Cooper
Lackman et al., "The Theory & Practice of Industrial Pharmacy" 2 Ed., 1976, pp. 235, 238-240.
Chemical Abstract, vol. 97, 1982, No. 174654.
Laboratori Fitocosmesi e Farmaceutici S.r.l.
Schenkman Leonard
LandOfFree
Use of 2,4 monofurfurylidene-sorbitol and its tetraalkyl derivat does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of 2,4 monofurfurylidene-sorbitol and its tetraalkyl derivat, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of 2,4 monofurfurylidene-sorbitol and its tetraalkyl derivat will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-778554